(Q35118406)

6 August 2017

title

Can prostate specific antigen velocity thresholds decrease insignificant prostate cancer detection? (English)

1 reference

6 August 2017

1 reference

Stacy Loeb

1

1 reference

6 August 2017

Kimberly A Roehl

2

1 reference

6 August 2017

Brian T Helfand

3

1 reference

6 August 2017

Donghui Kan

4

1 reference

6 August 2017

William J Catalona

5

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

6 August 2017

1 reference

6 August 2017

volume

183

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

112-116

1 reference

Screening and prostate-cancer mortality in a randomized European study

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140466

Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140466

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140466

Percentage carcinoma as a measure of prostatic tumor size in radical prostatectomy tissues.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140466

The Pathological Features and Prognosis of Prostate Cancer Detectable With Current Diagnostic Tests

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140466

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140466

PSA velocity is associated with gleason score in radical prostatectomy specimen: marker for prostate cancer aggressiveness

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140466

Prostate specific antigen velocity in men with total prostate specific antigen less than 4 ng/ml

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140466

Use of classical and novel biomarkers as prognostic risk factors for localised prostate cancer: a systematic review

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3140466

Rate of Change in Serum Prostate Specific Antigen Levels as a Method For Prostate Cancer Detection

27 September 2018

1 reference

12 December 2020

The Nature of Prostate Cancer Detected Through Prostate Specific Antigen Based Screening

1 reference

12 December 2020

The distribution of serum prostate-specific antigen levels among American men: implications for prostate cancer prevalence and screening

1 reference

12 December 2020

Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening

1 reference

12 December 2020

Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy

1 reference

12 December 2020

10.1016/J.JURO.2009.08.156

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference